These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1146 related articles for article (PubMed ID: 18397848)

  • 41. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
    Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma].
    Xu Y; Fan J; Zhou J; Qiu SJ; Wu ZQ; Yu Y; Hang XW; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2101-4. PubMed ID: 17988527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
    Li T; Fan J; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY
    Ann Surg Oncol; 2011 Jul; 18(7):1955-63. PubMed ID: 21240562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.
    Regimbeau JM; Abdalla EK; Vauthey JN; Lauwers GY; Durand F; Nagorney DM; Ikai I; Yamaoka Y; Belghiti J
    J Surg Oncol; 2004 Jan; 85(1):36-41. PubMed ID: 14696085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M; Grazi GL; Principe A; Ravaioli M; Ercolani G; Cescon M; Varotti G; Gardini A; Cavallari A
    Hepatogastroenterology; 2004; 51(56):510-4. PubMed ID: 15086193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resection prior to liver transplantation for hepatocellular carcinoma.
    Belghiti J; Cortes A; Abdalla EK; Régimbeau JM; Prakash K; Durand F; Sommacale D; Dondero F; Lesurtel M; Sauvanet A; Farges O; Kianmanesh R
    Ann Surg; 2003 Dec; 238(6):885-92; discussion 892-3. PubMed ID: 14631225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of cell-cycle modulators to predict vascular invasion and recurrence after surgical treatment of hepatocellular carcinoma.
    Ramos E; Lladó L; Serrano T; Figueras A; Lastra R; Torras J; Figueras J; Rafecas A; Fabregat J
    Transplantation; 2006 Sep; 82(6):753-8. PubMed ID: 17006321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
    Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
    Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Shah SA; Tan JC; McGilvray ID; Cattral MS; Cleary SP; Levy GA; Greig PD; Grant DR
    Transplantation; 2006 Jun; 81(12):1633-9. PubMed ID: 16794527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
    Pérez-Saborido B; de los Galanes SJ; Menéu-Díaz JC; Romero CJ; Elola-Olaso AM; Suárez YF; Valencia VB; Moreno-González E
    Transplant Proc; 2007 Sep; 39(7):2304-7. PubMed ID: 17889172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation.
    Bigourdan JM; Jaeck D; Meyer N; Meyer C; Oussoultzoglou E; Bachellier P; Weber JC; Audet M; Doffoël M; Wolf P
    Liver Transpl; 2003 May; 9(5):513-20. PubMed ID: 12740796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.